Cervical cancer: developments in screening and evaluation of the abnormal Pap smear
about
Plasma protein profiles differ between women diagnosed with cervical intraepithelial neoplasia (cin) 1 and 3.Regression of human papillomavirus intraepithelial lesions is induced by MVA E2 therapeutic vaccine.Preferences for human papillomavirus testing with routine cervical cancer screening in diverse older women.
P2860
Cervical cancer: developments in screening and evaluation of the abnormal Pap smear
description
1998 nî lūn-bûn
@nan
1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Cervical cancer: developments in screening and evaluation of the abnormal Pap smear
@ast
Cervical cancer: developments in screening and evaluation of the abnormal Pap smear
@en
Cervical cancer: developments in screening and evaluation of the abnormal Pap smear
@nl
type
label
Cervical cancer: developments in screening and evaluation of the abnormal Pap smear
@ast
Cervical cancer: developments in screening and evaluation of the abnormal Pap smear
@en
Cervical cancer: developments in screening and evaluation of the abnormal Pap smear
@nl
prefLabel
Cervical cancer: developments in screening and evaluation of the abnormal Pap smear
@ast
Cervical cancer: developments in screening and evaluation of the abnormal Pap smear
@en
Cervical cancer: developments in screening and evaluation of the abnormal Pap smear
@nl
P2860
P1476
Cervical cancer: developments in screening and evaluation of the abnormal Pap smear
@en
P2093
P2860
P304
P407
P577
1998-11-01T00:00:00Z